Survivin expression in canine epidermis and in canine and human cutaneous squamous cell carcinomas

Veterinary Dermatology

Volumn 20, Issue 5-6, 2009, Pages 369-376

  Bongiovanni, Laura ^a   Colombi, Isabella ^a   Fortunato, Carmine ^b   Salda, Leonardo Della ^a  

^a UNIVERSITY OF TERAMO   (Italy)

^b San Liberatore Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIRC5 PROTEIN, HUMAN; CYSTEINE PROTEINASE INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MITOSIS; PHYSIOLOGY; RETROSPECTIVE STUDY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CYSTEINE PROTEINASE INHIBITORS; DOG DISEASES; DOGS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MITOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

CANIS FAMILIARIS;

EID: 73149096014     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2009.00822.x     Document Type: Article

References (48)

1. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Medicine 1997 3 : 917 921.
2. Mahotka C, Wenzel M, Springer E et al. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Research 1999 59 : 6097 6102.
3. Caldas H, Jiang Y, Holloway MP et al. Survivin splice variants regulate the balance between proliferation and cell death. Oncogene 2005 24 : 1994 2007.
4. Badran A, Yoshida A, Ishikawa K et al. Identification of a novel splice variant of the human anti-apoptosis gene survivin. Biochemical and Biophysical Research Communications 2004 314 : 902 907.
5. Uchide T, Takatsu N, Fujimori Y et al. Expression of survivin mRNA in dog tumors. DNA sequence 2005 16 : 329 334.
6. Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nature Reviews. Cancer 2008 8 : 61 70.
7. Dohi T, Beltrami E, Wall NR et al. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. Journal of Clinical Investigation 2004 114 : 1117 1127.
8. Zaffaroni N, Pennati M, Dandone MG. Survivin as a target for new anticancer interventions. Journal of Cellular and Molecular Medicine 2005 9 : 360 372.
9. Grossman D, McNiff JM, Li F et al. Expression of the apoptosis inhibitor, survivin, in non melanoma skin cancer and gene targeting in a keratinocyte cell line. Laboratory Investigation 1999 79 : 1121 1126.
10. Bowen AR, Hanks AN, Murphy KJ et al. Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias. American Journal of Dermatopathology 2004 26 : 177 181.
11. Chiodino C, Cesinaro AM, Ottani D et al. Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. Journal of Investigative Dermatology 1999 113 : 415 418.
12. Lo Muzio L, Staibano S, Pannone G et al. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Experimental and Molecular Pathology 2001 70 : 249 254.
13. Markham T, Mathews C, Rogers S et al. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy. British Journal of Cancer 2006 155 : 1191 1196.
14. Botchkareva NV, Kahn M, Ahluwalia G et al. Survivin in the human hair follicle. Journal of Investigative Dermatology 2007 127 : 479 482.
15. Marconi A, Dallaglio K, Lotti R et al. Survivin identifies keratinocyte stem cells and is downregulated by anti-beta1 integrin during anoikis. Stem Cells 2007 25 : 149 155.
16. Simonetti O, Lucarini G, Bernardini ML et al. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study. British Journal of Dermatology 2004 150 : 940 948.
17. Scase TJ, Edwards D, Miller J et al. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. Journal of Veterinary Internal Medicine 2006 20 : 151 158.
18. Thomas J, Liu T, Cotter MA et al. Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice. Cancer Research 2007 67 : 5172 5178.
19. Abdou AG, Hanout HM. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study. Journal of Cutaneous Pathology 2008 35 : 445 451.
20. Allen SM, Florell SR, Hanks AN et al. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. Cancer Research 2003 63 : 567 572.
21. Park HR, Min SK, Cho HD et al. Expression profiles of p63, p53, survivin, and hTERT in skin tumors. Journal of Cutaneous Pathology 2004 31 : 544 549.
22. Gross TL, Ihrke PJ, Walder EJ et al. Epidermal tumors; follicular tumors. In : Gross TL, Ihrke PJ, Walder EJ, Affolter VK, eds. Skin Diseases of the Dog and Cat, 2nd edn. Oxford, UK : Blackwell Publishing Ltd, 2005 : 562 603 604-640.
23. Weedon D Tumors of the epidermis. In : Weedon D, ed. Skin Pathology. London, Churchill Livingstone, 2002 : 753 802.
24. Scott DW, Miller WH, Griffin CE Environmental skin diseases; neoplastic and non-neoplastic tumors. In : Muller & Kirk's Small Animal Dermatology, 6th edn. Philadelphia, W.B. Saunders Company, 2001 : 1073 1111 1236-1414.
25. Goldschmidt MH, Dunstan RW, Stannard AA et al. Histological classification of epithelial and melanocytic tumors of the skin of domestic animals. World Health Organization, International Histological Classification of Tumors of Domestic Animals, Armed Forces Institute of Pathology, American Registry of Pathology, Washington, DC 1998 : 20 2.
26. Kawasaki H, Altieri DC, Lu CD et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Research 1998 58 : 5071 5074.
27. Li F. Survivin study: what is the next wave? Journal of Cellular Physiology 2003 197 : 8 29.
28. Li F, Yang J, Ramnath N et al. Nuclear or cytoplasmic expression of survivin: what is the significance? International Journal of Cancer 2005 114 : 509 512.
29. Aziz MH, Ghotra AS, Shukla Y et al. Ultraviolet-B radiation causes an upregulation of survivin in human keratinocytes and mouse skin. Photochemistry and Photobiology 2004 80 : 602 608.
30. Grossman D, Kim PJ, Blanc-Brude OP et al. Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. Journal of Clinical Investigation 2001 108 : 991 999.
31. Grabowski P, Kühnel T, Mühr-Wilkenshoff F et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. British Journal of Cancer 2003 88 : 115 119.
32. Lu B, Gonzalez A, Massion PP et al. Nuclear survivin as a biomarker for non-small-cell lung cancer. British Journal of Cancer 2004 91 : 537 540. (Pubitemid 39093575)
33. Fields AC, Cotsonis G, Sexton D et al. Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome. Modern Pathology 2004 17 : 1378 1385.
34. Shinohara ET, Gonzalez A, Massion PP et al. Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma. Cancer 2005 103 : 1685 1692.
35. Preuss SF, Weinell A, Molitor M et al. Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. British Journal of Cancer 2008 98 : 627 632.
36. Vischioni B, van der Valk P, Span SW et al. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Annals of Oncology 2004 15 : 1654 1660.
37. Fukuda S, Pelus LM. Survivin, a cancer target with an emerging role in normal adult tissues. Molecular Cancer Therapeutics 2006 5 : 1087 1098.
38. O'Connor DS, Grossman D, Plescia J et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proceedings of the National Academy of Sciences of the USA 2000 97 : 13103 13107.
39. Lo Muzio L, Pannone G, Staibano S et al. Survivin expression in oral squamous cell carcinoma. British Journal of Cancer 2003 89 : 2244 2248.
40. Pizem J, Cör A, Gale N. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology 2004 45 : 180 186.
41. Kawasaki H, Toyoda M, Shinohara H et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 2001 91 : 2026 2032.
42. Kim HS, Shiraki K, Park SH. Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Research 2002 22 : 805 808.
43. Singh M, Bleile MJ, Shroyer AL et al. Analysis of survivin expression in a spectrum of benign to malignant lesions of the breast. Applied Immunohistochemistry & Molecular Morphology 2004 12 : 296 304.
44. Bongiovanni L, Romanucci M, Fant P et al. Apoptosis and anti-apoptotic heat shock proteins in canine cutaneous infundibular keratinizing acanthomas and squamous cell carcinomas. Veterinary Dermatology 2008 19 : 271 279.
45. Duffy MJ, O'Donovan N, Brennan DJ et al. Survivin: a promising tumor biomarker. Cancer Letters 2007 249 : 49 60.
46. Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends in Molecular Medicine 2001 7 : 542 547.
47. Altieri DC. Validating survivin as a cancer therapeutic target. Nature Reviews Cancer 2003 3 : 46 54.
48. Altieri DC. Targeted therapy by disabling crossroad signaling networks: the survivin paradigm. Molecular Cancer Therapeutics 2006 5 : 478 482.